HYDRALAZINE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Hydralazine And Hydrochlorothiazide patents expire, and what generic alternatives are available?
Hydralazine And Hydrochlorothiazide is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in HYDRALAZINE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for HYDRALAZINE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDRALAZINE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for HYDRALAZINE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Center for Research Resources (NCRR) | Phase 4 |
Vanderbilt University Medical Center | Phase 4 |
Vanderbilt University Medical Center | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for HYDRALAZINE AND HYDROCHLOROTHIAZIDE
US Patents and Regulatory Information for HYDRALAZINE AND HYDROCHLOROTHIAZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | HYDRALAZINE AND HYDROCHLOROTHIAZIDE | hydralazine hydrochloride; hydrochlorothiazide | TABLET;ORAL | 085827-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |